These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 6487440

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Diagnosis of disposition for malignant hyperthermia--an updated review based on 1,001 studies].
    Olthoff D, Deutrich C, Meinecke CD.
    Anaesthesiol Reanim; 1997; 22(2):32-40. PubMed ID: 9235003
    [Abstract] [Full Text] [Related]

  • 43. In vitro contracture tests in patients with various neuromuscular diseases.
    Heytens L, Martin JJ, Van de Kelft E, Bossaert LL.
    Br J Anaesth; 1992 Jan; 68(1):72-5. PubMed ID: 1739572
    [Abstract] [Full Text] [Related]

  • 44. Analysis of histomorphology in malignant hyperthermia-susceptible patients.
    Orlov D, Keith J, Rosen D, Croul S, Kraeva N, Riazi S.
    Can J Anaesth; 2013 Oct; 60(10):982-9. PubMed ID: 23888335
    [Abstract] [Full Text] [Related]

  • 45. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
    Hackl W, Winkler M, Mauritz W, Steinbereithner K.
    Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
    [Abstract] [Full Text] [Related]

  • 46. [In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study].
    Schuster F, Hager M, Metterlein T, Muellenbach RM, Wurmb T, Wunder C, Roewer N, Anetseder M.
    Anaesthesist; 2008 Aug; 57(8):767-74. PubMed ID: 18563374
    [Abstract] [Full Text] [Related]

  • 47. Pharmacological in-vitro studies in malignant hyperthermia in childhood.
    Mortier W, Biesel C.
    Brain Dev; 1982 Aug; 4(5):347-52. PubMed ID: 7137513
    [Abstract] [Full Text] [Related]

  • 48. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS, Lerman J, Cunliffe M, McLeod ME, Britt BA.
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
    Flewellen EH, Nelson TE.
    Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma.
    Nelson TE, Flewellen EH, Gloyna DF.
    Anesth Analg; 1983 Jun; 62(6):545-52. PubMed ID: 6846875
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Screening test for malignant hyperthermia in patients with persistent hyperCKemia: a pilot study.
    Johannsen S, Berberich C, Metterlein T, Roth C, Reiners K, Roewer N, Schuster F.
    Muscle Nerve; 2013 May; 47(5):677-81. PubMed ID: 23400941
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.